Adolore Biotherapeutics
Adolore Biotherapeutics is a startup headquartered in Delray Beach, United States, founded in 2021. It has raised at least $1.1m in outside funding, according to its filings with the US Securities and Exchange Commission (Form D), which puts it at the seed stage.
Part of the 311 Institute Global Startups Directory (311institute.com). Last updated .
Funding
Adolore Biotherapeutics has raised at least $1.1m in outside funding, according to its Form D filings with the US Securities and Exchange Commission. Form D figures are a minimum: not every round is filed.
R&D ecosystem
Adolore Biotherapeutics sits inside the Jupiter region R&D ecosystem in the Global R&D Labs Directory.
Other startups in Delray Beach
Related
Questions and answers
What does Adolore Biotherapeutics do?
Adolore Biotherapeutics is classed in biotechnology in its filings with the US Securities and Exchange Commission.
How much has Adolore Biotherapeutics raised?
At least $1.1m, according to its Form D filings with the US Securities and Exchange Commission.
Where is Adolore Biotherapeutics based?
Adolore Biotherapeutics is headquartered in Delray Beach, United States.
When was Adolore Biotherapeutics founded?
Adolore Biotherapeutics was founded in 2021.
Source record: SEC EDGAR (Form D filings).
© 311 Institute 2026. Facts from the official sources linked on this page. The selection, classification and links are the proprietary work of the 311 Institute, protected by copyright and database rights.